Vnitr Lek 2013, 59(1):13-15

Liečba AL-amyloidózy v roku 2012, prínos nových liekov - editorial

E. Tóthová
Ústav lekárskej a klinickej biofyziky Lekárskej fakulty UPJŠ Košice, Slovenská republika, prednosta doc. RNDr. Ján Sabo, CSc., mim. prof.

Received: December 30, 2012; Published: January 1, 2013  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Tóthová E. Liečba AL-amyloidózy v roku 2012, prínos nových liekov - editorial. Vnitr Lek. 2013;59(1):13-15.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Dispenzieri A, Gertz MA, Buadi F. What do I need to know about immunoglobulin light chain (AL) amyloidosis? Blood Reviews 2012; 26: 137-154. Go to original source... Go to PubMed...
    2. Comenzo RL, Reece D, Palladini G et al. Consensus guidelines for the conduct and reporting of clinical trials in systemic light-chain (AL) amyloidosis. Leukemia: official Journal of the Leukemia Society of America. Leukemia Research Fund, UK, 2012. Go to original source... Go to PubMed...
    3. Reece DE, Hegenbart U, Sanchorawala V et al. Efficacy and safety of once-weekly and twice-weekly bortezomib in patients with relapsed systemic AL amyloidosis: results of phase 1/2 study. Blood 2011; 118: 865-873. Go to original source... Go to PubMed...
    4. Klippel ZK, Storer B, Bensinger W et al. Improved stem cell transplant related mortality for AL amyloidosis at a single transplant center. 54th ASH. Annual Meeting and exposition, Atlanta, GA, December 8-11, 2012, abstr. 2016. Go to original source...
    5. Sanchorawala V, Shelton A, Braunen D et al. Treatment of AL amyloidosis with two cycles of induction therapy with bortezomib and dexamethasone followed by bortezomib-high dose melphalan conditioning and auto-logous stem cell transplantation. 54th ASH, Atlanta, GA, December 8-11, 2012, abstr. 2019. Go to original source...
    6. Desport E, Bridoux F, Sirac CH. AL amyloidosis. Orphanet Journal of Rare Diseases 2012; 54: 1-13. Go to original source... Go to PubMed...

    Return to the content


    Vnitřní lékařství

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.